Literature DB >> 15117908

Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.

José R Banegas1, Julián Segura, Luis M Ruilope, Manuel Luque, Rafael García-Robles, Carlos Campo, Fernando Rodríguez-Artalejo, Juan Tamargo.   

Abstract

Goal blood pressure (BP) was defined by the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI) and the World Health Organization-International Society of Hypertension (WHO/ISH) as <140 mm Hg systolic and <90 mm Hg diastolic for the general and <130 mm Hg systolic and <85 mm Hg diastolic for special high-risk populations. However, there are few reports that address BP control among special subgroups of hypertensives by reference to targeted BP. We therefore conducted a study to evaluate BP control of 4049 hypertensives in 47 hospital-based hypertension units in Spain. Overall, 42% of patients achieved goal BP (<140 mm Hg systolic and <90 mm Hg diastolic). Only 13% of diabetic patients and 17% of those with renal disease achieved the BP goal (<130 mm Hg systolic and <85 mm Hg diastolic), and only 10% and 12%, respectively, achieved the even more rigorous goal (<130 mm Hg systolic and <80 mm Hg diastolic). Likewise, only 18% of patients in JNC-VI risk group C and 17% of WHO/ISH high-risk patients attained a goal BP <130 mm Hg systolic and <85 mm Hg diastolic. BP control (<125 mm Hg systolic and <75 mm Hg diastolic) was extremely low (2%) in patients with proteinuria >1 g/d. Poorer BP control was observed among patients at high risk, with diabetes, renal disease, or obesity, than in lower-risk groups. BP control was lower for systolic than for diastolic BP. In >50% of uncontrolled patients, no measures were taken by doctors to optimize pharmacologic treatment, and approximately one-third of patients were still using drug monotherapy. Control of BP, particularly of systolic BP, is still far from optimal in hospital-based hypertension units. Patients at high risk, with diabetes or proteinuria, warrant focused attention. Moreover, a more aggressive behavior of doctors treating uncontrolled hypertension is needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117908     DOI: 10.1161/01.HYP.0000127424.59774.84

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

Review 1.  Intermediate versus hard end points in clinical trials on hypertension.

Authors:  Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

2.  [Prevention of therapeutic inertia in the treatment of arterial hypertension by using a program of home blood pressure monitoring].

Authors:  Emilio Márquez Contreras; José Luis Martín de Pablos; Jacinto Espinosa García; José Joaquín Casado Martínez; Eugenio Sanchez López; José Escribano
Journal:  Aten Primaria       Date:  2011-10-20       Impact factor: 1.137

Review 3.  Hypertension Survey in Italy: Novel Findings from the Campania Salute Network.

Authors:  Eugenio Stabile; Raffaele Izzo; Francesco Rozza; Maria Angela Losi; Nicola De Luca; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-01

4.  [Objective KONTROL study: therapeutic inertia in hypertensive patients attended in primary care of Spain].

Authors:  Carlos Sanchis Doménech; José Luis Llisterri Caro; Vicente Palomo Sanz; Francisco Javier Alonso Moreno; Isidro López Rodríguez; Armando Nevado Loro; Miguel Ángel Zamorano; Natividad Gil García; M Dolores Aguilar Conesa; Pablo Lázaro Y de Mercado
Journal:  Aten Primaria       Date:  2011-03-17       Impact factor: 1.137

Review 5.  Combination drug treatment of hypertension: have we come full circle?

Authors:  Addison A Taylor
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 6.  Can we justify goal blood pressure of <140/90 mm Hg in most hypertensives?

Authors:  Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

7.  [Durability of the effects of a quality improvement intervention in hypertensive patients on long-term follow-up (CICLO-RISK study)].

Authors:  Manuel Angel Gómez Marcos; Emiliano Rodríguez Sánchez; Emilio Ramos Delgado; Carmen Fernández Alonso; Angel Luis Montejo Gónzalez; Luis García Ortiz
Journal:  Aten Primaria       Date:  2009-05-15       Impact factor: 1.137

Review 8.  Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.

Authors:  Bernard Waeber; François Feihl; Luis M Ruilope
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  [Current situation of hypertensive patients over 75 years old: the DISEHTAE study].

Authors:  Antonio Martínez Pastor; Mariano Leal Hernández; Luis Alberto Vara González; Luis Javier González Elena; Eduardo Paja Fano; Juan López Abril
Journal:  Aten Primaria       Date:  2008-05       Impact factor: 1.137

10.  [Control of therapeutic inertia in the treatment of arterial hypertension by using different strategies].

Authors:  Emilio Márquez Contreras; Nieves Martel Claros; Vicente Gil Guillén; José Luis Martín De Pablos; Mariano De La Figuera Von Wichman; José Joaquin Casado Martínez; Jacinto Espinosa García
Journal:  Aten Primaria       Date:  2009-05-31       Impact factor: 1.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.